Steven Tropello, MD, MS Founder, CMO

Steven Tropello, MD, MS

Founder, CMO

Dr. Tropello is an Emergency and Critical Care Physician with a master's in Systems and Computer Engineering.  Dr. Tropello worked briefly at JP Morgan as a business solutions IT consultant before refocusing on his other passion, medicine. He attended the University of Virginia School of Medicine for both medical school and a residency in Emergency Medicine where he functioned as Chief Resident. After residency, Dr. Tropello and his family moved to Baltimore where he completed a fellowship in Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine. Following medical training Dr. Tropello has continued to live in Baltimore City and work in both Emergency and Critical Care Medicine. He has faculty appointments at both the University of Maryland School of Medicine and the Johns Hopkins University School of Medicine where he continues research on medical devices and health IT systems respectively.

In 2013 while working clinically at the University of Maryland, Dr. Tropello became frustrated when he was unable to immediately treat a patient with a feeding tube malfunction, causing the patient to be admitted needlessly overnight - and leading to the birth of Coaptive Ultrasound.  Dr. Tropello is the inventor and primary developer of Coaptive Ultrasound platform applications, hoping to use the platform technology to help his patients in clinical practices as soon as possible. He will serve as founder and medical lead for CoapTech in order to help the company grow swiftly and deploy applications worldwide.

 
Howard Carolan,  MPH, MBA    Co-Founder, CEO

Howard Carolan,  MPH, MBA   

Co-Founder, CEO

Mr. Carolan has worked at the Johns Hopkins Armstrong Institute for Patient Safety and Quality (“A.I.”) and at the Johns Hopkins Center for Innovation in Quality Patient Care.  At A.I. he served as lead Project Manager for development of “Emerge” in partnership with the Johns Hopkins Applied Physics Laboratory.  Emerge is a transdisciplinary program based on Systems Engineering principles that designed and developed computer applications with clinicians for improving medical care and patient experience.  

In his 9 years with Johns Hopkins, Mr. Carolan has been involved with a number of strategic and operational projects spanning the healthcare continuum, with a focus on patient safety, quality improvement, revenue enhancement, and information technology.   Howard’s interest in these areas was forged at the Johns Hopkins Bloomberg School of Public Health, where he earned his MPH, received an NIH grant for Public Health Informatics training, and served as President of the Anna Baetjer Society for Public Health.  Mr. Carolan also completed his MBA from the Johns Hopkins Carey Business School with a focus in health care.  He has co-authored publications in the areas of patient safety, systems engineering, computerized clinician decision support, pay-for-performance, Venous Thromboembolism prevention, and is currently pursuing research in trans-disciplinary approaches to quality and safety in health care.  Mr. Carolan is a graduate of Duke University where he received his Bachelor of Science in economics.  

Elisabeth (Liz) Goldwasser, BSME  Vice President of Engineering

Elisabeth (Liz) Goldwasser, BSME 

Vice President of Engineering

Jack Kent Chief Commercialization Officer

Jack Kent

Chief Commercialization Officer

Elisabeth (Liz) Goldwasser has over a decade of product development experience, having led several large programs and multidisciplinary teams with a focus on design for manufacturing, quality, and human factors.   As the Vice President of Engineering for CoapTech, she brings with her a keen interest in improving the lives of both doctors and patients through simple and effective novel technologies, and a drive to mentor and support the next generation of biomedical engineers.  Liz graduated with a Bachelor of Science in Mechanical Engineering from the University of Maryland in 2003. 

She has retained ties to her alma mater through her affiliation with the Robert E. Fischell Department of Bioengineering where she has brought other medical device concepts to fruition, and is part of the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) team, an FDA-funded collaboration between UMD’s Clark School of Engineering and Children’s National Medical Center’s Sheikh Zayed Institute for Pediatric Surgical Innovation where she is managing an effort to create and provide open-source FDA and ISO 13485 compliant Quality Management System templates for the biomedical device community.  Ms. Goldwasser also volunteers with the UMD Alumni Association, where she serves on the Board of Governors and as President of the Engineering Alumni Network. 

Mr. Kent is an experienced medical device executive with significant prior work leading companies in efforts to deliver novel technology and positively impact patient care. In his most recent endeavor, Mr. Kent directed 6 product development projects from concept to delivery. These products are now available in the United States, the European Union, and Canada. His team successfully navigated FDA reviews, CE Mark reviews, FDA inspections, and ISO 13485 Notified Body audits – among other activities.  Mr. Kent has worked with diverse product types, ranging in specialty (e.g., IR, GI, ORTH), use (therapeutic/diagnostic), and other characteristics (e.g., electrical, single-use vs. reusable, sterile/nonsterile, software). 

Additionally, Mr. Kent has focused his career on assisting start-up companies navigate the complex environment surrounding medical devices.  Mr. Kent also hopes to foster economic growth in Maryland through the development of novel technologies. To this end, he studied innovation and entrepreneurship at Johns Hopkins University, earning two masters degrees (in business and public health). Mr. Kent previously served as Managing Director, Innovative Healthcare Products, at Becker & Associates Consulting, a boutique consulting firm located in Washington, D.C. Mr. Kent holds a B.S.E. in Bioengineering from the Univ. of Pennsylvania, as well as MBA and MPH degrees from Johns Hopkins University.